DPA en es it fr

Categoria

DPA Nombres de marca, DPA Analogos

DPA Marca los nombres de mezcla

  • No information avaliable
  • DPA Formula quimica

    C16H31NaO4

    DPA RX enlace

    http://www.rxlist.com/cgi/generic/dival.htm

    DPA FDA hoja

    DPA FDA

    DPA MSDS (hoja de seguridad de materiales)

    DPA Sintesis de referencia

    No hay información disponible

    DPA Peso molecular

    310.405 g/mol

    DPA Punto de fusion

    222oC

    DPA H2O Solubilidad

    Ligeramente soluble (2000 mg / L)

    DPA Estado

    Solid

    DPA LogP

    2.549

    DPA Formas de dosificacion

    Tablet (con cubierta entérica - 125, 250, 500 mg)

    DPA Indicacion

    Para el tratamiento y manejo de los trastornos convulsivos, manía, y el tratamiento profiláctico de la migraña.

    DPA Farmacologia

    Divalproex es un establo de coordinación compuesto compuesto de valproato de sodio y el ácido valproico en una relación 1:1 molar y formado durante la neutralización parcial de ácido valproico con 0.5 equivalentes de hidróxido de sodio. Divalproex es un anticonvulsivo y estabilizadores del ánimo medicamento que se usa principalmente en el tratamiento de la epilepsia y el trastorno bipolar. También se utiliza para tratar la migraña y la esquizofrenia. En los epilépticos, divalproex se utiliza para controlar las crisis de ausencia, convulsiones tónico-clónicas (gran mal), convulsiones parciales complejas, y las crisis asociadas al síndrome de Lennox-Gastaut. Divalproex se cree para afectar la función del neurotransmisor GABA (como un inhibidor de la transaminasa GABA) en el cerebro humano. Divalproex disocia al ion valproato en el tracto gastrointestinal.

    DPA Absorcion

    Rápida absorción del tracto gastrointestinal.

    DPA Toxicidad

    Sobredosificación con valproato puede resultar en somnolencia, bloqueo cardíaco y coma profundo. Las muertes se han reportado, sin embargo los pacientes se han recuperado de los niveles de valproato tan altos como 2,120 mcg / ml.

    DPA Informacion de Pacientes

    Important Information for Women Who Could Become Pregnant About the Use of DEPAKOTE® (divalproex sodium) Tablets

    Please read this leaflet carefully before you take DEPAKOTE® (divalproex sodium) tablets. This leaflet provides a summary of important information about taking DEPAKOTE to women who could become pregnant. If you have any questions or concerns,or want more information about DEPAKOTE, contact your doctor or pharmacist.

    Information For Women Who Could Become Pregnant

    DEPAKOTE can be obtained only by prescription from your doctor. The decision to use DEPAKOTE is one that you and your doctor should make together, taking into account your individual needs and medical condition.

    Before using DEPAKOTE, women who can become pregnant should consider the fact that DEPAKOTE has been associated with birth defects, in particular, with spina bifida and other defects related to failure of the spinal canal to close normally. Approximately 1 to 2% of children born to women with epilepsy taking DEPAKOTE in the first 12 weeks of pregnancy had these defects (based on data from the Centers for Disease Control, a U.S. agency based in Atlanta). The incidence in the general population is 0.1 to 0.2%.

    Information For Women Who Are Planning to Get Pregnant

    ï Women taking DEPAKOTE who are planning to get pregnant should discuss the treatment options with their doctor.

    Information For Women Who Become Pregnant While Taking DEPAKOTE

    ï If you become pregnant while taking DEPAKOTE you should contact your doctor immediately.

    Other Important Information About DEPAKOTE Tablets

    ï DEPAKOTE tablets should be taken exactly as it is prescribed by your doctor to get the most benefits from DEPAKOTE and reduce the risk of side effects.

    ï If you have taken more than the prescribed dose of DEPAKOTE, contact your hospital emergency room or local poison center immediately.

    ï This medication was prescribed for your particular condition. Do not use it for another condition or give the drug to others.

    Facts About Birth Defects

    It is important to know that birth defects may occur even in children of individuals not taking any medications or without any additional risk factors.

    This summary provides important information about the use of DEPAKOTE to women who could become pregnant. If you would like more information about the other potential risks and benefits of DEPAKOTE, ask your doctor or pharmacist to let you read the professional labeling and then discuss it with them. If you have any questions or concerns about taking DEPAKOTE, you should discuss them with your doctor.

    DPA Organismos afectados

    Humanos y otros mamíferos